Pharma Foods International Co., Ltd. provided consolidated earnings guidance for the year ending July 31, 2023. For the year, the company expects net sales of ¥71,000 million, operating profit of ¥1,191 million, profit attributable to owners of parent of ¥886 million or earnings per share of ¥30.47.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
877 JPY | +0.57% | -0.45% | -12.48% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.48% | 158M | |
+34.57% | 50.85B | |
+0.49% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.98% | 26.11B | |
-21.59% | 19.13B | |
+8.41% | 13.05B | |
+27.13% | 12.16B | |
+24.46% | 12.08B |
- Stock Market
- Equities
- 2929 Stock
- News Pharma Foods International Co., Ltd.
- Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2023